The following information is obtained from various newswires,
published medical journal articles, and medical conference presentations.
Company: Elan
Approval Status: Approved September 1997
Treatment for: anticonvulsant and trigeminal neuralgia
General Information
Carbatrol by Elan Corp. has been approved as a treatment for epileptic seizures and trigeminal neuralgia. Carbatrol is recommended for use twice daily as an extended release drug.